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Evidence for a Specific Defect in Hippocampal
Memory in Overt and Subclinical Hypothyroidism
Neuman Correia,* Sinead Mullally,* Gillian Cooke, Tommy Kyaw Tun,
Niamh Phelan, Joanne Feeney, Maria Fitzgibbon, Gerard Boran, Shane O’Mara,
and James Gibney
Departments of Endocrinology (N.C., T.K.T., N.P., J.G.) and Chemical Pathology (G.B.), Adelaide and
Meath Hospital, incorporating the National Children’s Hospital, Tallaght, Dublin 24, Ireland; and Trinity
College Institute of Neuroscience (S.M., G.C., J.F., M.F., S.O.), Dublin 2, Ireland
Context: Declarative memory largely depends upon normal functioning temporal lobes (hip-
pocampal complex) andprefrontal cortex.Animal studies suggest abnormalhippocampal function
in hypothyroidism.
Objective: The aim of the study was to assess declarative memory in overt and subclinical (SCH)
hypothyroid patients before and after L-T4 (LT4) replacement and in matched normal subjects.
Design and Setting:Aprospective, open-labeled interventional studywas conducted at a teaching
hospital.
Participants and Intervention: Hypothyroid (n  21) and SCH (n  17) patients underwent neu-
ropsychological tests at baseline and 3 and 6months after LT4 replacement. Normal subjects were
studied at the same time-points.
MainOutcome: Tests of spatial, verbal, associative, andworkingmemory; attention; and response
inhibition and the Hospital Anxiety and Depression Scale were administered.
Results:Baselinedeficits inspatial,associative,andverbalmemory,whichrelyuponthe integrityof the
hippocampal and frontal areas, were identified in patients with overt hypothyroidism. Spatial and
verbalmemorywereimpairedinSCHpatients (P0.05).TSHlevelscorrelatednegatively(P0.05)with
these deficits. After LT4 replacement, verbal memory normalized. Spatial memory normalized in the
SCH group but remained impaired in the hypothyroid group. Associativememory deficits persisted in
the overt hypothyroid group. Hospital Anxiety and Depression Scale scores did not correlate with
cognitive function.Measures of attentionand response inhibitiondidnot differ fromcontrol subjects.
Conclusion: Cognitive impairment occurs in SCH and more markedly in overt hypothyroidism.
These impairments appear predominantlymnemonic in nature, suggesting that the etiology is not
indicative of general cognitive slowing. We propose that these deficits may reflect an underlying
disruption of normal hippocampal function and/or connectivity. (J Clin Endocrinol Metab 94:
3789–3797, 2009)
Although impairment of cognitive function in overt hy-pothyroidism has been recognized for more than a
century, the nature and severity of this impairment and the
degree of recovery after treatment remain unclear (1).
Some studies have reported general cognitive slowing (2,
3), whereas others suggest a more specific mnemonic def-
icit (4, 5). Deficits in hippocampal-dependent memory
tasks (6) that are reversiblewith thyroid hormone replace-
ISSN Print 0021-972X ISSN Online 1945-7197
Printed in U.S.A.
Copyright © 2009 by The Endocrine Society
doi: 10.1210/jc.2008-2702 Received December 11, 2008. Accepted July 1, 2009.
First Published Online July 7, 2009
* N.C. and S.M. contributed equally to this work.
Abbreviations: FT4, Free T4; LT4, L-T4; ROCF, Rey-Osterrieth Complex Figure (task); SCH,
subclinical hypothyroidism.
O R I G I N A L A R T I C L E
E n d o c r i n e C a r e
J Clin Endocrinol Metab, October 2009, 94(10):3789–3797 jcem.endojournals.org 3789
ment (7–9) are apparent in animal models of hypothy-
roidism, whereas studies in hypothyroid rats have dem-
onstrated impaired hippocampal neurogenesis, providing
a potential mechanistic explanation for these mnemonic
deficits (10). It is not known whether similar mnemonic
deficits occur in humans.
It is also not known whether the neurocognitive deficits
associatedwith overt hypothyroidism occur in patientswith
subclinical hypothyroidism (SCH), which is defined as per-
sistently raised serum TSH level in the presence of normal
free T4 (FT4) and which occurs in 4–10% of the adult pop-
ulation (11). Although some studies suggest impairment of
cognitive function in SCH, there remain inconsistencies in
the range and degree of these deficits.One study reported an
attenuation of logical memory (12), whereas other investi-
gations point to specific deficits inworkingmemory (13, 14)
or verbal fluency (15). These apparently conflicting findings
potentially reflect differences in the age of the populations
studied, differing degrees of severity of SCH, and a lack of
uniformity in administered cognitive tests.
We hypothesized that specific impairments in hippocam-
pal andpossibly frontally drivenmemory processes could be
demonstrated in subjects with overt hypothyroidism and to
a lesserdegree inSCH,andthesedeficitswould improveafter
L-T4 (LT4) replacement. To address this, we conducted a
battery of cognitive tests shown previously to be sensitive to
deficits in hippocampal- and frontally driven cognitive pro-
cesses. We tested patients with overt and subclinical hypo-
thyroidism before and after LT4 replacement and normal
control subjects matched for age and educational status.
Control subjects were retested at 3 and 6 months to control
for learning effects. We assessed anxiety and depression,
which are more marked in hypothyroid (2, 16) patients and
couldpotentially confoundassessmentof cognitive function.
Patients and Methods
Participants
Twenty-one patients with hypothyroidism (FT4  11 pmol/
liter; elevated TSH), and 17 patients with SCH (TSH  4 mU/
liter; normal FT4), ages 18–65 yr, participated in this study. The
majority of patients were recruited from General Practitioner
referrals to Endocrinology outpatient service, the remainder be-
ing direct referrals to the Endocrinology department from other
specialist teams within the hospital. Nineteen healthy control
subjects of similar age and education were recruited. All partic-
ipants were native English speakers. Exclusion criteria included
a previous history of ischemic heart disease, stroke, diabetes,
head injury, epilepsy, psychiatric illness, significant visual im-
pairment, or pregnancy. Care was taken to avoid testing during
periods of significant stress (e.g. death of relative). All study
subjects gave theirwritten signed consent to the study,whichwas
approved by the Research Ethics Committee of the Adelaide and
Meath Hospital and St. James’s Hospital (Dublin, Ireland).
Experimental design
At diagnosis, a neurocognitive battery of memory and exec-
utive function tasks was performed (session 1), lasting approx-
imately 1 h (including a 5-min break midway through the ses-
sion). SCH and hypothyroid subjects were commenced on LT4
replacement after initial neurocognitive assessment; they had an
additional thyroid hormone level checked 6 wk after commenc-
ing LT4. LT4 was prescribed as an initial dose of 50 g/d and
subsequently titrated depending on TSH levels. Cognitive func-
tioning and thyroid hormone levels were reassessed at approx-
imately 3-month (session 2) and 6-month (session 3) intervals.
When possible, alternative versions of cognitive tests were ad-
ministered at each session to minimize practice effects.
Neurocognitive battery
We selected tasks that focused specifically on general intelli-
gence, anxiety and depression levels, learning, memory, and ex-
ecutive functioning. The tests were administered in the same
order to all participants by a single tester whowas not blinded to
the subject group. An estimate of premorbid intelligence was
obtained using the National Adult Reading Test (17), and self-
reported mood and well-being were obtained using the Hospital
Anxiety and Depression Scale (18).
Tests for declarative memory were: visual memory, the Rey-
Osterrieth Complex Figure; verbal memory, the Rivermead Be-
havioral Memory Test: Story Recall Subset; and associative
memory, Face-Name Learning and Recall. Tests for executive
function were: focused attention; working memory, n-Back
Task; and response inhibition, the Stroop Task.
Declarative memory tests
Visual memory: the Rey-Osterrieth Complex Figure (ROCF).
The ROCF was designed to measure visuospatial ability and non-
verbal memory (19, 20) and is sensitive to medial temporal lobe
damage (21, 22). It consists of a two-dimensional line drawing that
participants are required to copy as accurately as possible (Copy
Trial,maximumscore36).Twentyminutes later, theyredrawthe
figure frommemory(DelayedRecallTrial),andamemoryaccuracy
score is calculated (DelayedRecall/CopyTrial100). TheModified
Taylor Complex Figure (23), a comparable version of the ROCF,
was used at session 2 to minimize practice effects across sessions.
Note: the ROCF was readministered at session 3.
Verbal memory: the Rivermead BehavioralMemory Test: Story
Recall Subset. The Rivermead Behavioral Memory Test (24) is
used to assess grossmemory impairments and has been shown to
correlate with everyday memory complaints (25). This verbal
subset consists of a paragraph of four sentences (21 units) that
are read out to the subject. Subjects are then required to recall the
story in as much detail as possible at the immediate and delayed
(30 min after learning) levels.
Associativememory:Face-NameLearningandRecall.This task
represents an ecologically valid measure of associative learning.
Clinical and neuroimaging data suggest that this ability depends
principally on the hippocampal formation (26). Subjects were
required to encode (memorize) and subsequently recall eight
novel face-name pairs that were presented on a computer screen.
They performed four successive learning and recall trials (Face-
Name Encoding), followed by a Delayed Recall Trial (Face-
Name Recall; 15 min after learning).
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Executive function tests
Focused attention. Each of the four encoding and recall trials in
the face-name task was separated by a 30-sec visual attention
task. Participants were required to respond to a rapid and re-
petitive visual stimulus. This sought to prevent subvocal re-
hearsal of the pairs and offered a brief measure of focused
attention.
Workingmemory: then-BackTask(0-Back,1-Back,and2-Back
Levels). The n-Back Working Memory Task was performed at
three levels of difficulty (0-, 1-, and 2-Back). The 0-Back level
represents a sensorimotor control, whereas the 1- and 2-Back
levels place incrementally increasing working-memory loads
(27). Successful performance on this task is believed to depend
upon the integrity of the dorsolateral prefrontal cortex (28–30).
Response inhibition: the StroopTask—NamingColoredWords
version. This task assessed the subject’s ability to make an ap-
propriate response when presented with two conflicting stimuli
(31). Subjects were presented with one of four words (red, yel-
low, green, blue) on a computer screen in red, yellow, green, or
blue font. Subjects were instructed to respond to the font color
of the word displayed on screen (using a color-coded response
pad). Therefore, a behavioral conflict occurred when there was
a mismatch between the meaning of the written word and the
font color (e.g.“RED”). Resolution of this conflict (which re-
quires the exertion of control mechanisms) is believed to require
the successful engagement of areas such as the anterior cingulate
cortex and dorsolateral prefrontal cortex (32).
Analytic measurement
Using the DPC Immulite 2000 analyzer (Diagnostic Products
Corp., Los Angeles, CA), serum TSH concentrations were mea-
sured using a third-generation chemiluminescent immunometric
assay and FT4 was measured using a competitive analog immu-
noassay (coefficient of variation 5% for all).
Statistical analysis
Analyses were carried out using SPSS (version 14) for PC
(SPSS Inc., Chicago, IL). All data were expressed as means SE,
unless specified otherwise. ANOVA was the primary statistical
tool used. When performance on a specific task was repeated
across multiple trials and/or testing sessions “mixed between-
within subject ANOVAs” (33) were used to compare perfor-
mance across the repeated levels and between the groups.Where
significant (P  0.05), main effects and interactions were ob-
served and, if appropriate, post hoc analyses were conducted.
Subsequent one-way ANOVAs compared the dependent vari-
able at each level (trial and/or session) between the groups. In the
presence of significance between-group differences, a priori
planned comparisons were used to test specific differences be-
tween the SCH and control groups (comparison 1) and the hy-
pothyroid and control groups (comparison 2). A Bonferroni ad-
justment to the  level (/no. of comparisons; 0.05/2  0.025)
was applied to these comparisons to maintain a reasonable 
level across all tests. Note: group differences are reported for the
SCHandhypothyroid groups relative to control group only. The
relationship betweenTSH levels and all dependent variableswas
investigated using Pearson correlations. Due to a lack of nor-
mality in the TSH data, the data were transformed using a Log10
transformation.
Results
No differences in age, gender, or education level were ob-
servedbetween the control, SCH, andhypothyroid groups
(Table 1). Significant differences in TSH and FT4 levels
between SCH and hypothyroid compared with controls
are also shown in Table 1.
Results of predicted IQ scores and levels of anxiety and
depression are displayed in Fig. 1. Predicted full-scale IQ
was significantly lower in the hypothyroid group, but not
in the SCH patients comparedwith controls. Predicted IQ
did not change in any of the groups after treatment. A
significant positive correlationwas found between IQ and
performance at the Rivermead Behavioral Memory Task
and theFace-NameLearning andRecall task. Before treat-
ment, scores of anxiety and depression were significantly
elevated in SCH and hypothyroid patients compared with
controls. Although there was improvement observed in
both groups after LT4 replacement, scores remained ele-
vated compared with control subjects by the end of the
study. However, no correlations were observed between
reported anxiety or depression levels and any of the ad-
ministered cognitive tasks [with the exception of depres-
sion levels and verbal recall (Rivermead short stories, im-
mediate level; r  0.352; P  0.05)], suggesting that
depression or anxiety levels did not significantly influence
measured cognitive abilities.
Pretreatment cognitive profiles
Results of tests of visual, verbal, and working memory
are displayed in Fig. 2.
Visual memory: the ROCF Task
A significant deficit was also noted in hypothyroid pa-
tients at the copy level, indicating an impairment of visuo-
spatial constructional ability. Due to this deficit, themem-
ory accuracy score (delayed recall/copy100) was used to
assess mnemonic performance at the delayed recall level.
An overall group differencewas observed here, suggesting
that thyroid dysfunction impaired visual memory (P 
0.001).Posthocanalysis revealed significantdeficits in the
TABLE 1. Comparison of control, SCH, and hypothyroid
groups
Control SCH Hypothyroid
n 19 17 21
Age (yr) 46.1  9.3 50.0  9.2 44.0  10.9
Females:males 19:0 16:1 20:1
Education (yr) 13.3  2.8 12.8  2.2 12.5  3.1
TSH (mU/liter) 1.3 (0.4–2.1) 6.1 (4.4–13.6) 38.9 (10.8–75.0)
FT4 (pmol/liter) 16.3 (13.6–19.2) 12.8 (10.7–16.3) 7.6 (3.5–10.0)
Age and education level are presented as mean  SD. TSH and FT4
levels are expressed as median (minimum-maximum) due to a high
level of kurtosis in the data.
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hypothyroid group, and in the SCH group comparedwith
control subjects.
Verbal memory: the Rivermead Behavioral Memory
Test: Short-Stories Subset
Significant verbalmemory deficitswere found in both the
immediate (P 0.001) and delayed recall (P 0.001) of the
short story. Comparedwith normal subjects, both hypothy-
roid and SCH groups recalled significantly fewer units im-
mediately after story exposure (Immediate Recall) and 30
minafter learning(DelayedRecall), indicating impairment in
verbal memory.
Working memory and attention: the n-Back Task
(0-Back, 1-Back, and 2-Back levels)
No significant group differences were observed at any
of the three levels of the n-Back Task. A trend toward
significance was, however, noted at the 1-Back level (P
0.072). This trendwas not evident at the 2-Back level (P
0.169), although these results should be interpreted with
caution because fewer patients were actually able to at-
tempt the task [16% of control participants, 47% of SCH
patients, and 33% of hypothyroid patients withdrew at
the 2-Back level].
Associative memory: Face-Name Learning and Recall
Results of tests of associative memory are displayed in
Fig. 3. The total face-name pairs successfully encoded
(blocks 1–4) differed significantly between groups (P 
0.05). Although this differencewas statistically significant
only between the hypothyroid and control groups, a strong
trendtowardsignificancewasobserved inpatientswithSCH
(P  0.039;   0.05/2; Bonferroni corrected). There was
also a strong trend (P0.05) toward a significant difference
between hypothyroid and control subjects in the Delayed
Recall Trial.
Focused attention task
No significant group differences were observed.
Response inhibition: the Stroop Task
Mean performance accuracy (per-
centage) and reaction times (millisec-
onds)were comparedacross the two tri-
als (congruent and incongruent) and
between groups. Although an overall
significant difference in performance
accuracy was found across the two trial
types (P  0.001), indicating that in-
congruent trials were more difficult
than congruent trials, no trial by group
interactions or overall group differ-
ences were observed. No difference be-
tween the groups was observed when the congruent and
incongruent trials were compared.
TSH correlations
Table 2 summarizes performance of SCH and hypo-
thyroid groups on the cognitive tasks compared with
controls, correlations with pretreatment TSH and per-
formance improvement after treatment. Pretreatment
TSH levels correlated negatively and significantly with
predicted IQ, visuospatial construction ability, and
visuospatial, verbal, associative, and working memory.
No significant correlations were observed between TSH
levels and measures of attention or response inhibition.
Effects of treatment on cognitive functioning
The effect of LT4 replacement on tests of visual, verbal,
and working memory are displayed in Fig. 2.
Visual memory: the ROCF task
Changes in performance between the three groups,
across the three testing sessions [session 1 (baseline) vs.
session 2 (3 months) vs. session 3 (6 months)], were
assessed. Despite strong main effects of Session (P 
0.001) and Group (P  0.01), no significant Group 
Session interaction was observed. However, the ob-
served baseline impairment in SCH patients’ perfor-
mance no longer differed from that of the control group
at the 3-month time-point, whereas the hypothyroid
group remained impaired throughout. Deficits in visuo-
spatial constructional ability (copy trial) in the hypo-
thyroid group observed at baseline were no longer ev-
ident at the 3-month time-point.
Verbal memory: the Rivermead Behavioral Memory
Test: Short-Stories Subset
Changes in performance between the three groups and
across the three testing sessions and two task levels (im-
mediate and delayed recall) were assessed. A significant
interaction between Group and Session (P  0.01) was
FIG. 1. Pretreatment patient profiles. A, Predicted full scale IQ, derived using the National
Adult Reading Test. B, Scores obtained on the Hospital Anxiety and Depression scale; the
dotted lines indicate the point at which the anxiety/depression score is considered to reflect
probable/severe levels of anxiety/depression.
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observed.A substantialmain effect for Session (P0.001)
reflected the improved performance of both patient
groups after LT4 replacement. A significantmain effect of
Group (P  0.01) was also evident and was further ex-
plored using one-way ANOVAs. At the 3-month time-
point, significant differences in immediate and delayed
recall remained between hypothyroid and control groups,
but were no longer apparent between SCH and control
groups.At the 6-month time-point, no between-groupdif-
ferences could be demonstrated.
Working memory: the n-Back Task (0-Back, 1-Back,
and 2-Back levels)
Performance accuracy at the 0-Back level was assessed
between groups and across sessions. No SessionGroup
interaction or main effects of Session or Group were ob-
served. These analyses were repeated for the 1-Back and
2-Back performance accuracy scores, and again, no
Group Session interactionswere observed.A significant
main effect of group was, however, found at the 1-Back
level (P  0.05); with the hypothyroid group performing
FIG. 2. A, The ROCF Task. Mean ( SEM) units accurately drawn at copy and 30 min later from memory in the control, subclinical hypothyroid and
hypothyroid groups across the three testing sessions (pretreatment, 3 and 6 months of LT4 treatment). B, The Rivermead Short Stories Task. Mean
( SEM) units recalled immediately and 30 min later. C, n-Back Working Memory Task. Mean ( SEM) performance accuracy, across the three
testing sessions, at the 1-Back and 2-Back levels.
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less accurately than controls (P0.05).One-wayANOVAs
confirmed this difference at the 3-month, but not the
6-month, time-point.
To further elucidate this change in working memory
ability across the 6 months of follow-up, paired-sample
t-tests were conducted (exploring the change in perfor-
mance accuracy between baseline and the 3-month time-
point). No change in 1-Back performancewas observed in
the control group, whereas both the SCH (P 0.056) and
the hypothyroid (P  0.061) tended to improve at the
6-month time-point compared with baseline. Compliance
issues confounded interpretation of the 2-Back data, but
similar trends were observed at this level.
Associative memory: Face-Name Learning and Recall
(Fig. 3)
Changes in performance between the three groups,
across the three testing sessions, were explored. A signif-
icant Group  Session interaction (P  0.05) was ob-
served, indicating a differential change in the groups’ as-
sociative memory abilities across the testing sessions. An
overall significant main effect of Group (P  0.01) was
consistent with the observed impairment of associative
memory in hypothyroid subjects observed in the baseline
studies. Hypothyroid patients (P  0.01) remained sig-
nificantly different relative to controls at the 3- and
6-month time-points.
Despite the nonsignificant baseline deficit observed on
this measure (see Pretreatment cognitive profiles), SCH
patients showed the greatest level of improved perfor-
mance between sessions (see Fig. 3, Improvement Score).
This performance change reflects the difference in perfor-
mance between session 3 relative to session 1, while con-
trolling for the corresponding change in the control group.
The significantly enhanced performance observed in the
SCH group relative to the control group (P 0.025) dem-
onstrates that the SCH group improved significantly be-
yond “practice effects” after 6 months of treatment. As
indicated above, a corresponding effect of treatment was
not evident in the hypothyroid group (P  0.92).
Focused attention
Meanperformance accuracy across the four blockswas
compared across the three sessions, revealing no Session
Group interaction or main effects of either Session or
Group.
Response inhibition: the Stroop Task
Changes in performance accuracy between the three
groups and across the three testing Sessions and two Trial
Types (congruent and incongruent trials) revealed no Ses-
sion Group, or Session Group Trial-Type interac-
tions. Overall performance accuracy was not compro-
mised in this population, and analyses revealed no overall
groupdifference at anyof the three testingpoints for either
congruent or incongruent trials. No group differences
were observed when reaction time data were considered.
Discussion
This cross-sectional and interventional study provides
preliminary evidence that a specific deficit in memory
rather thanageneral cognitive slowing is present inovertly
hypothyroid patients, and to a lesser extent in SCH pa-
tients. We observed deficits in visuospatial, verbal, and
associativememory before LT4 treatment. After 6months
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of LT4 replacement, patients with SCHno longer differed
from normal control subjects, but many deficits persisted
in the hypothyroid group.
SCH patients demonstrated significant improvements
after 3 months of LT4 replacement onmeasures of visual-
spatial and verbal memory. In contrast, hypothyroid pa-
tients remained impaired relative to control subjects on the
memory component of the visual-spatial task and the as-
sociative memory task despite LT4 replacement. Perfor-
mance improved at the copy trial of the visual memory
task (becoming comparable to control subjects at 3
months) and on the verbal memory task by 6 months.
There are a number of possible interpretations of this dif-
ferential response. Firstly, the cognitive deficits observed
in overt hypothyroidism might not be reversible, suggest-
ing a critical time-window during which these cognitive
deficits may be alleviated. Notably, in patients with con-
genital hypothyroidism, amelioration of spatial learning
andmemorydeficits afterLT4replacement treatment is only
observedwhen treatment is initiatedwithin a critical stageof
neural development (34). An alternative explanation is that
the deficits resolve over a longer period of time. Finally, we
cannot rule out the possibility of an enhanced practice effect
in SCH compared with overtly hypothyroid patients, al-
though the lack of any improvement in the control group
across the three sessions makes this less likely.
Although impairments in working memory have been
reported (2), our study revealed no significant group dif-
ferences at baseline. However, abnormalities in working
memory have been observed in cross-sectional studies of
hypothyroid patients on stable LT4 replacement, suggest-
ing that thismemory domain does not completely respond
to restoration of euthyroid status (35). In the current
study, no significant difference in working memory was
observed between SCH and control subjects, consistent
with those of Jorde et al. (36). In contrast, deficits in
working memory were described in subjects with ex-
perimentally induced SCH (13), but TSH levels were
more elevated in this group, implying a more marked
degree of hypothyroidism.
Not all of our findings were consistent with those re-
portedby Jorde et al. (36).Mostnotably,wedemonstrated
deficits in the visual and verbal memory in SCH patients.
These results should be interpreted with caution because
ourpatients largelypresented to their generalpractitioners
with symptoms that prompted measurement of thyroid
TABLE 2. Performance of SCH and hypothyroid groups on the cognitive tasks compared with controls, correlations
with pretreatment TSH, and performance improvement after treatment
Impaired
(pretreatment)a TSH
correlationsb
Normalized (T4 treatment)
c
SCH H SCH H
Cognitive domain
General intelligence, NART P  0.59 P  0.01 0.33* No
Visual-spatial construction, ROCF copy level P  0.76 P  0.025 0.27* Yes (3 months)
Visual-spatial memory, ROCF memory
accuracy score
P  0.025 P  0.001 0.47*** Yes (3 months) No
Verbal memory
Immediate story recall P  0.001 P  0.001 0.52*** Yes (3 months) Yes (6 months)
Delayed story recall P  0.001 P  0.001 0.55*** Yes (3 months) Yes (6 months)
Associative memory
Face-Name encoding P  0.039ˆ P  0.025 0.31*  (3 months) No
Face-Name delayed recall P  0.124 P  0.025 0.31* No
Working memory, 1-Back Task P  0.072ˆ P  0.072ˆ 0.30*
Focused attention, Circle Task P  0.072ˆ P  0.072ˆ N.S.
Response inhibition, Stroop Task: incongruent
trials
P  0.529 P  0.529 N.S.
Affective domain
Anxiety rating (HADS) P  0.01 P  0.01 0.31* No,  (3 months) No,  (3 months)
Depression rating (HADS) P  0.01 P  0.01 0.32* No,  (3 months) No,  (3 months)
NART, National Adult Reading Test; HADS, Hospital Anxiety and Depression Scale; N.S., not significant.
a Pretreatment cognitive and affective profiles: A summary of cognitive abilities in both SCH and hypothyroid patient groups, relative to the control
group, reported either in terms of the results of the overall between-group comparisons (nonsignificant findings) or in terms of a priori planned
comparisons performed after a significant group difference. In these latter cases, the  level is set at 0.025 to control for multiple comparisons
(0.05/2 comparisons). All analyses reported were performed on the performance accuracy scores obtained on each task.
b Relationship between measured cognitive abilities (plus anxiety/depression ratings) and pretreatment TSH levels.
c Change in task performance after 3 and 6 months of LT4 treatment, relative to pretreatment ability. Symbols indicate significant between-group
differences at the corresponding  level: *, P  0.05; ***, P  0.001. ˆ, Incidences where P was observed to be approaching significance; , a
significant improvement relative to the within-group baseline level.
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hormones, a potential selection bias. Importantly, no dif-
ferenceswere observedonattentionor response inhibition
tasks in hypothyroid or SCH subjects, potentially indicat-
ing that cognitive deficits are not generalized but are pos-
sibly specific to hippocampal and frontal areas (37). Pre-
vious studies in hypothyroid patients have generally (36,
38) but not always reported similar findings (35).
Anxiety and depression scores were higher in both
groups compared with control subjects, but there were no
correlations with any of our measures of cognitive func-
tion. These observations are consistent with previous re-
ports inwhich improvement of depressive symptoms after
LT4 replacement has not been associated with improve-
ment in cognitive function (5, 35, 39).
Further limitations of the study design should be con-
sidered. Larger study numbers would have increased the
sensitivity to detect abnormal findings. Tests investigating
attention and working memory in greater detail would
have augmented our findings but would significantly
lengthen the test battery.
In summary, we observed an apparent selective mne-
monic deficit in hypothyroid and SCH patients. Evidence
from animal models suggests that thyroid hormones play
a role in the regulation of neuron formation. Thyroid hor-
mone receptors are known to be in abundance in the hip-
pocampal area, and the hormone does play a role in neu-
rogenesis in the adult brain. Thyroid hormone deficiency
results in a delay in neuronal differentiation, resulting in a
reduction in size and number of granule cells in the hip-
pocampus (40). The mnemonic measures on which we
observed the impaired performances are believed to de-
pend upon the integrity of the hippocampus and frontal
cortex (41). In addition, the face-name encoding task
found to be significantly impaired in overt hypothyroid-
ism is closely linked to underlying hippocampal activity
(26). We conclude that neurocognitive impairments spe-
cific to memory-related cortical areas are demonstrable in
patients with overt and subclinical hypothyroidism.
Moreover, in light of the apparent sparingof attention and
response inhibition processes in both SCH and hypothy-
roid groups, together with animal data, we propose that
these memory deficits may be more indicative of an un-
derlying hippocampal deficit, rather than a frontal lobe
problem, although the exact underlying neuronal deficits
will require further elucidation.
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